100 related articles for article (PubMed ID: 17912027)
1. The pilot study of anti-tumor effects versus immunosuppression of Staphylococcal Enterotoxin C.
Jie KG; Jiang H; Sun L; Wang HR; Zheng YL; Li Y; Jiang YQ
Cancer Biol Ther; 2007 Oct; 6(10):1584-91. PubMed ID: 17912027
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
3. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
5. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
7. Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer.
Liu T; Li L; Yin L; Yu H; Jing H; Liu Y; Kong C; Xu M
Biosci Biotechnol Biochem; 2017 Sep; 81(9):1741-1746. PubMed ID: 28715277
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment.
Izeradjene K; Revillard JP
Transplantation; 2001 Jan; 71(1):118-25. PubMed ID: 11211176
[TBL] [Abstract][Full Text] [Related]
9. Unique features of bovine lymphocytes exposed to a staphylococcal enterotoxin.
Park YH; Lee SU; Ferens WA; Samuels S; Davis WC; Fox LK; Ahn JS; Seo KS; Chang BS; Hwang SY; Bohach GA
J Vet Sci; 2006 Sep; 7(3):233-9. PubMed ID: 16871017
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
Davison S; Allen M; Vaughan R; Barker J
Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
[TBL] [Abstract][Full Text] [Related]
11. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
12. FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL.
Migita K; Origuchi T; Kawabe Y; Tominaga M; Ida H; Kawakami A; Eguchi K
Transplantation; 1999 Oct; 68(7):1018-23. PubMed ID: 10532544
[TBL] [Abstract][Full Text] [Related]
13. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro antitumor effects of a staphylococcal enterotoxin A mutant (SEA-H61D).
Wang HR; Jiang H; Hao HJ; Zheng YL; Jie KG; Gu J; Jiang YQ
Cancer Invest; 2010 Oct; 28(8):788-96. PubMed ID: 20504220
[TBL] [Abstract][Full Text] [Related]
15. Increased T-cell stimulating activity by mutated SEC2 correlates with its improved antitumour potency.
Liu Y; Xu M; Su Z; Cai Y; Zhang G; Zhang H
Lett Appl Microbiol; 2012 Nov; 55(5):362-9. PubMed ID: 22925007
[TBL] [Abstract][Full Text] [Related]
16. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
Rosendahl A; Kristensson K; Hansson J; Ohlsson L; Kalland T; Dohlsten M
Int J Cancer; 1998 Apr; 76(2):274-83. PubMed ID: 9537591
[TBL] [Abstract][Full Text] [Related]
18. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal enterotoxin B as a potent suppressant of T lymphocytes: trace levels suppress T lymphocyte proliferative responses.
Ben-Nun A; Yossefi S
Eur J Immunol; 1992 Jun; 22(6):1495-503. PubMed ID: 1376261
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice.
Kuschnaroff LM; Valckx D; Goebels J; Rutgeerts O; Heremans H; Froyent G; Waer M
Scand J Immunol; 1997 Nov; 46(5):459-68. PubMed ID: 9393628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
